No photo of Olli Ritvos
  • PL 63 (Haartmaninkatu 8)

    00014

    Finland

1987 …2019
If you made any changes in Pure these will be visible here soon.

Personal profile

Keywords

  • 3111 Biomedicine

International and National Collaboration Publications and projects within past five years.

Publications 1987 2019

  • 97 Article
  • 4 Review Article
  • 1 Conference article

Activin Receptor Ligand Blocking and Cancer Have Distinct Effects on Protein and Redox Homeostasis in Skeletal Muscle and Liver

Hentila, J., Nissinen, T. A., Korkmaz, A., Lensu, S., Silvennoinen, M., Pasternack, A., Ritvos, O., Atalay, M. & Hulmi, J. J., 18 Jan 2019, In : Frontiers in Physiology. 9, 16 p., 1917.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade

Lautaoja, J. H., Lalowski, M., Nissinen, T. A., Hentila, J., Shi, Y., Ritvos, O., Cheng, S. & Hulmi, J. J., May 2019, In : American Journal of Physiology: Endocrinology and Metabolism. 316, 5, p. E852-E865 14 p.

Research output: Contribution to journalArticleScientificpeer-review

Systemic Blockade of ACVR2B Ligands Protects Myocardium from Acute Ischemia-Reperfusion Injury

Magga, J., Vainio, L., Kilpio, T., Hulmi, J. J., Taponen, S., Lin, R., Räsänen, M., Szabo, Z., Gao, E., Rahtu-Korpela, L., Alakoski, T., Ulvila, J., Laitinen, M., Pasternack, A., Koch, W. J., Alitalo, K., Kivela, R., Ritvos, O. & Kerkelä, R., 6 Mar 2019, In : Molecular therapy. 27, 3, p. 600-610 11 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File

Prevention of chemotherapy-induced cachexia by ACVR2B ligand blocking has different effects on heart and skeletal muscle

Hulmi, J. J., Nissinen, T. A., Räsänen, M., Degerman, J., Lautaoja, J. H., Hemanthakumar, K. A., Backman, J. T., Ritvos, O., Silvennoinen, M. & Kivelä, R., Apr 2018, In : Journal of cachexia, sarcopenia and muscle. 9, 2, p. 417-432 16 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses

Nissinen, T. A., Hentilä, J., Penna, F., Lampinen, A., Lautaoja, J. H., Fachada, V., Holopainen, T., Ritvos, O., Kivelä, R. & Hulmi, J. J., Jun 2018, In : Journal of cachexia, sarcopenia and muscle. 9, 3, p. 514-529 16 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access
File